Amalgamated Bank’s Transphorm, Inc. Common Stock TGAN Stock Holding History

Amalgamated Bank’s Portfolio TGAN Stock Details TGAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-744	Closed	-$4K	–	3161
2024 Q1	$4K	Sell	744 -2,916	-80%	-$13.8K	﹤0.01%	2806
2023 Q4	$13K	Sell	3,660 -221	-6%	-$605	﹤0.01%	2824
2023 Q3	$9K	Hold	3,881	–	–	﹤0.01%	2922
2023 Q2	$13K	Buy	3,881 +766	+25%	+$2.76K	﹤0.01%	2921
2023 Q1	$12K	Sell	3,115 -476	-13%	-$2.1K	﹤0.01%	2787
2022 Q4	$20K	Hold	3,591	–	–	﹤0.01%	2758
2022 Q3	$18K	Buy	3,591 +202	+6%	+$995	﹤0.01%	2846
2022 Q2	$13K	Buy	+3,389	New	+$21.6K	﹤0.01%	2953

Amalgamated Bank's TGAN Position: Q2 2024 in Review

Amalgamated Bank sold out of Transphorm, Inc. Common Stock (TGAN) in Q2 2024, closing a stake of 744 shares — an estimated $4K sold.

Amalgamated Bank first reported a position in TGAN in Q2 2022 and held it in 8 quarters. The position peaked at $20K in Q4 2022. 0 funds tracked by Wall St. Rank hold TGAN as of Q2 2024.

Amalgamated Bank reported no remaining Transphorm, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Amalgamated Bank sold 744 Transphorm, Inc. Common Stock shares in Q2 2024, an estimated $4K.
Amalgamated Bank first reported a position in Transphorm, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
Amalgamated Bank's Transphorm, Inc. Common Stock position peaked at $20K in Q4 2022.
0 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q2 2024.

Based on Amalgamated Bank's 13F filing for Q2 2024, filed 12 Aug 2024.